Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults

Sathyabaarathi Ravichandran,Fernando Erra-Diaz,Onur E. Karakaslar,Radu Marches,Lisa Kenyon-Pesce,Robert Rossi,Damien Chaussabel,Djamel Nehar-Belaid,David C. LaFon,Virginia Pascual,Karolina Palucka,Silke Paust,Moon H. Nahm,George A. Kuchel,Jacques Banchereau,Duygu Ucar

DOI: https://doi.org/10.1038/s41590-023-01717-5

IF: 30.5

2024-01-06

Nature Immunology

Abstract:Pneumococcal infections cause serious illness and death among older adults. The capsular polysaccharide vaccine PPSV23 and conjugated alternative PCV13 can prevent these infections; yet, underlying immunological responses and baseline predictors remain unknown. We vaccinated 39 older adults (>60 years) with PPSV23 or PCV13 and observed comparable antibody responses (day 28) and plasmablast transcriptional responses (day 10); however, the baseline predictors were distinct. Analyses of baseline flow cytometry and bulk and single-cell RNA-sequencing data revealed a baseline phenotype specifically associated with weaker PCV13 responses, which was characterized by increased expression of cytotoxicity-associated genes, increased frequencies of CD16 + natural killer cells and interleukin-17-producing helper T cells and a decreased frequency of type 1 helper T cells. Men displayed this phenotype more robustly and mounted weaker PCV13 responses than women. Baseline expression levels of a distinct gene set predicted PPSV23 responses. This pneumococcal precision vaccinology study in older adults uncovered distinct baseline predictors that might transform vaccination strategies and initiate novel interventions.

immunology

What problem does this paper attempt to address?

This paper aims to explore the immune responses of the elderly to the conjugated pneumococcal polysaccharide vaccine (PCV13) and the unconjugated pneumococcal polysaccharide vaccine (PPSV23) and their baseline predictors. Specifically, the researchers hope to understand:

1. **Differences in vaccine responses**: Compare the intensity, range, and ranking of antibody responses of the two vaccines in the elderly population to evaluate their effectiveness.
2. **Baseline immune characteristics**: Identify baseline immune characteristics related to vaccine responses, especially those that can predict an individual's response to a specific vaccine.
3. **Effects of gender and age**: Analyze how gender and age affect the immune responses to these two vaccines.

Through these studies, the authors hope to provide more accurate vaccination strategies for the elderly population and develop new interventions to improve the effectiveness of vaccines. The study found that although both PCV13 and PPSV23 can induce strong antibody responses, there are significant differences in their baseline predictors. For example, men show higher CYTOX gene expression levels, which are associated with weaker PCV13 responses, while women show stronger PCV13 responses. In addition, the frequency of cytotoxic natural killer cells (CD16+ NK cells) at baseline is negatively correlated with PCV13 responses.

These findings are helpful for understanding the heterogeneity of different individuals' responses to vaccines and may guide the personalized use of future vaccines.